Arctic Root SHR-5

Arctic Root SHR-5 is the most studied and documented rhodiola rosea product in the world.

It is sold in Sweden and Norway as a THMP. It is used as an adaptogen against stress-related reduced performance with symptoms such as fatigue, feelings of weakness, irritability and mild anxiety.

Works as an adaptogen against stress-related

fatigue,
feelings of weakness
milder anxiety
emotional irritability

Arctic Root was the first rhodiola rosea product on the market. This is the reason why "Arctic root" has becoma a generic name for the plant.

The most documented rhodiola rosea extract in the world

SHR-5 rhodiola extract is the worlds most clinically studied and documented extract. Since the 90-ties Arctic Root has been the most popular rhodiola rosea product in Sweden.

Clinical studies of SHR-5 rhodiola rosea

SHR-5 VS SETRALINE – MILD TO MODERATE DEPRESSION - SHR-5 HAD SOMEWHAT LESS ANTIDEPRESSANT EFFECT BUT WAS BETTER TOLERATED WITH NO ADVERSE EFFECTS.
Rhodiola rosea vs. sertraline for major depressive disorder: A randomized placebo-controlled trial.
Mao JJ, Xie SX, Zee J, Soeller I, Li QS, Rockwell K, Amsterdam JD. Phytomedicine. 2015 Mar 15;22(3):394-9. doi: 10.1016/j.phymed.2015.01.010. https://pubmed.ncbi.nlm.nih.gov/25837277/

STUDY PROTOCOL WITH SHR-5 TREATMENT IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
Rhodiola rosea therapy for major depressive disorder: A study protocol for a randomized, double-blind, placebo-controlled trial. Mao JJ, Li QS, Soeller I, Xie SX, Amsterdam JD. Journal of Clinical Trials. 2014 Jun 20;4:170. doi: 10.4172/2167-0870.1000170. https://pubmed.ncbi.nlm.nih.gov/25610752/

SHR-5 TREAT STRESSED BURNOUT PATIENTS WITH FATIGUE SYNDROME
A randomised, double-blind, placebo-controlled, parallell-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue.
Olsson EMG, Von Schéele B, a. Panossian AG. Planta Med. 2009 Feb;75(2):105-12. doi: 10.1055/s-0028-1088346. https://pubmed.ncbi.nlm.nih.gov/19016404/

SHR-5 TREATS PATIENTS WITH MILD TO MODERATE DEPRESSION
Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression.
Darbinyan V, Aslanyan G, Amroyan E, Gabrielyan E, Malmström C, Panossian A. Nordic Journal of Psychiatry. 2007;61(5):343-8. doi: 10.1080/08039480701643290. https://pubmed.ncbi.nlm.nih.gov/17990195/

STUDY ON NORMAL AND DOUBLE DOSE SHR-5 ON CADETS DURING MENTAL WORK – NORMAL DOSAGE IS ENOUGH
A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Shevtsov VA, Zholus BI, Shervarly VI, Vol’skij VB, Korovin YP, Khristich MP, Roslyakova NA, Wikman G. Phytomedicine. 2003 Mar;10(2-3):95-105. doi: 10.1078/094471103321659780. https://pubmed.ncbi.nlm.nih.gov/12725561/

SHR-5 INCREASE MENTAL PERFORMANCE DURING PHYSICIANS NIGHT DUTY
Rhodiola rosea in stress induced fatigue – A double blind cross-over study of a standardized extract SHA-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Darbinyan V, Kteyan A, Panossian A, Gabrielian E, Wikman G, Wagner H.
Phytomedicine. 2000 Oct;7(5):365-71. doi: 10.1016/S0944-7113(00)80055-0. https://pubmed.ncbi.nlm.nih.gov/11081987/

SHR-5 IMPROVES STUDY RESULTS DURING STRESSFUL EXAMINATION PERIODS
A double-blind placebo-controlled pilot study of the stimulating effect of Rhodiola rosea SHR-5 extract on the physical and mental work capacity of students during a stressful examination period with a repeated low-dose regimen. Spasov AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin VV. Phytomedicine. 2000 Apr;7(2):85-9. doi: 10.1016/S0944-7113(00)80078-1. https://pubmed.ncbi.nlm.nih.gov/10839209/